Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Daniel, Peter Prof. Dr. (2) Janz, Martin Dr. (6) Kammertöns, Thomas Dr. (1) Kopp, Joachim Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (3) Lusatis, Simone (1) Mathas, Stephan Dr. (9) Pezzutto, Antonio Prof. Dr. (1) Siffrin, Volker (1) Uckert, Wolfgang Prof. Dr. (3) Walther, Wolfgang Prof. Dr. (2) (-) Blankenstein, Thomas Prof. Dr. (9) (-) Wollert-Wulf, Brigitte (3) Bioinformatik der Genregulation (2) (-) Biologie maligner Lymphome (3) Entwicklungsbiologie / Signaltransduktion in Nerven und Muskelzellen (1) Genetik und Genomik von Herz- Kreislauferkrankungen (2) Genomdiversifikation & Integrität (1) Immunregulation und Krebs (1) (-) Molekulare Immunologie und Gentherapie (9) Molekulare Physiologie der somatosensorischen Wahrnehmung (1) Proteom Dynamik (12) Proteomforschung und molekulare Mechanismen bei neurodegenerativen Erkrankungen (1) Proteomics and Metabolomics (2) RNA Biologie und Posttranscriptionale Regulation (1) Systembiologie von Gen-regulatorischen Elementen (2) 1992 (4) 1993 (7) (-) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) (-) 2006 (3) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) 2013 (13) 2014 (3) (-) 2015 (4) 2016 (4) 2017 (6) 2018 (4) 2019 (7) 2021 (4) 2022 (6) 2023 (6) 2024 (2) 12 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Wollert-Wulf, BrigitteBiologie maligner LymphomeMolekulare Immunologie und Gentherapie 199420062015 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Januar 1994 / Br J Canc Expression of interleukin 10 in human melanoma S. Krueger-Krasagakes K. Krasagakis C. Garbe E. Schmitt C. Huels T. Blankenstein T. Diamantstein 01. Januar 1994 / Folia Biol Observations with tumour necrosis factor gene-transfected tumours T. Blankenstein 01. Januar 1994 / Eur J Cancer Increasing tumour immunogenicity by genetic modification T. Blankenstein 01. Januar 1994 / Canc Res Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL- 10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma- A. Allione M. Consalvo P. Nanni P.L. Lollini F. Cavallo M. Giovarelli M. Forni A. Gulino M.P. Colombo P. Dellabona H. Hock T. Blankenstein F.M. Rosenthal B. Gansbacher M.C. Bosco T. Musso L. Gusella G. Forni 01. Januar 1994 / Nat Immun Tumor-cell-targeted cytokine gene transfer in experimental models for cancer therapy H. Hock M. Dorsch G. Richter U. Kunzendorf S. Krueger-Krasagakes T. Blankenstein Z.H. Qin T. Diamantstein 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 01. April 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber 01. April 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. Januar 1994 / Br J Canc Expression of interleukin 10 in human melanoma S. Krueger-Krasagakes K. Krasagakis C. Garbe E. Schmitt C. Huels T. Blankenstein T. Diamantstein
01. Januar 1994 / Folia Biol Observations with tumour necrosis factor gene-transfected tumours T. Blankenstein
01. Januar 1994 / Eur J Cancer Increasing tumour immunogenicity by genetic modification T. Blankenstein
01. Januar 1994 / Canc Res Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL- 10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma- A. Allione M. Consalvo P. Nanni P.L. Lollini F. Cavallo M. Giovarelli M. Forni A. Gulino M.P. Colombo P. Dellabona H. Hock T. Blankenstein F.M. Rosenthal B. Gansbacher M.C. Bosco T. Musso L. Gusella G. Forni
01. Januar 1994 / Nat Immun Tumor-cell-targeted cytokine gene transfer in experimental models for cancer therapy H. Hock M. Dorsch G. Richter U. Kunzendorf S. Krueger-Krasagakes T. Blankenstein Z.H. Qin T. Diamantstein
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
01. April 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
01. April 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein